|
|||||
|
|
Frequent rectal gastrointestinal stromal tumor recurrences in the imatinib era: Retrospective analysis of an International Patient Registry |
|
| Authors: | Emelia Stuart BS Sudeep Banerjee MD Jorge de la Torre MD Yu Wang PhD Norman Scherzer JD Adam M. Burgoyne MD PhD Lisa Parry MD Paul T. Fanta MD Sonia Ramamoorthy MD Jason K. Sicklick MD |
| Affiliation: | 1. School of Medicine, University of California, San Diego, California Emelia Stuart and Sudeep Banerjee contributed equally to this study.;2. Division of Surgical Oncology, Department of Surgery, Moores Cancer Center, University of California, San Diego, California Department of Surgery, David Geffen School of Medicine at UCLA, Los Angeles, California Emelia Stuart and Sudeep Banerjee contributed equally to this study.;3. Division of Surgical Oncology, Department of Surgery, Moores Cancer Center, University of California, San Diego, California;4. Life Raft Group, Wayne, New Jersey;5. School of Medicine, University of California, San Diego, California Division of Hematology Oncology, Department of Medicine, Moores Cancer Center, University of California, San Diego, California;6. School of Medicine, University of California, San Diego, California Division of Colorectal Surgery, Department of Surgery, Moores Cancer Center, University of California, San Diego, California;7. School of Medicine, University of California, San Diego, California |
| Abstract: | |
| Keywords: | gastrointestinal stromal tumor imatinib rectal mass submucosal tumor |